M. Lipinski, G. Biondi-zoccai, A. Abbate, R. Khianey, I. Sheiban et al., Impact of Intracoronary Cell Therapy on Left Ventricular Function in the Setting of Acute Myocardial Infarction, Journal of the American College of Cardiology, vol.50, issue.18, pp.1761-1767, 2007.
DOI : 10.1016/j.jacc.2007.07.041

E. Martin-rendon, S. Brunskill, C. Hyde, S. Stanworth, A. Mathur et al., Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review, European Heart Journal, vol.29, issue.15, pp.1807-1818, 2008.
DOI : 10.1093/eurheartj/ehn220

T. Dill, V. Schachinger, R. A. Mollmann, S. Thiele, H. Tillmanns et al., Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: Results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac Magnetic Resonance Imaging substudy, American Heart Journal, vol.157, issue.3, pp.541-547, 2009.
DOI : 10.1016/j.ahj.2008.11.011

G. Meyer, K. Wollert, J. Lotz, J. Pirr, U. Rager et al., Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial, European Heart Journal, vol.30, issue.24, pp.2978-2984, 2009.
DOI : 10.1093/eurheartj/ehp374

M. Tendera, W. Wojakowski, W. Ruzyllo, L. Chojnowska, C. Kepka et al., Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial, European Heart Journal, vol.30, issue.11, pp.1313-1321, 2009.
DOI : 10.1093/eurheartj/ehp073

J. Roncalli, F. Mouquet, C. Piot, J. Trochu, C. Le et al., Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial, European Heart Journal, vol.32, issue.14, pp.1748-1757, 2011.
DOI : 10.1093/eurheartj/ehq455

URL : https://hal.archives-ouvertes.fr/inserm-00543644

S. Janssens, C. Dubois, J. Bogaert, K. Theunissen, C. Deroose et al., Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial, The Lancet, vol.367, issue.9505, pp.113-121, 2006.
DOI : 10.1016/S0140-6736(05)67861-0

S. Dimmeler and A. Leri, Aging and Disease as Modifiers of Efficacy of Cell Therapy, Circulation Research, vol.102, issue.11, pp.1319-1330, 2008.
DOI : 10.1161/CIRCRESAHA.108.175943

F. Cao, D. Sun, C. Li, K. Narsinh, L. Zhao et al., Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up, European Heart Journal, vol.30, issue.16, pp.1986-1994, 2009.
DOI : 10.1093/eurheartj/ehp220

S. Grajek, M. Popiel, L. Gil, P. Breborowicz, M. Lesiak et al., Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation, European Heart Journal, vol.31, issue.6, pp.691-702, 2010.
DOI : 10.1093/eurheartj/ehp536

A. Hirsch, R. Nijveldt, P. Van-der-vleuten, J. Tijssen, W. Van-der-giessen et al., Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial, European Heart Journal, vol.32, issue.14, pp.1736-1747, 2011.
DOI : 10.1093/eurheartj/ehq449

H. Huikuri, K. Kervinen, M. Niemela, K. Ylitalo, M. Saily et al., Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction, European Heart Journal, vol.29, issue.22, pp.2723-2732, 2008.
DOI : 10.1093/eurheartj/ehn436

K. Lunde, S. Solheim, S. Aakhus, H. Arnesen, M. Abdelnoor et al., Intracoronary Injection of Mononuclear Bone Marrow Cells in Acute Myocardial Infarction, New England Journal of Medicine, vol.355, issue.12, pp.1199-1209, 2006.
DOI : 10.1056/NEJMoa055706

M. Plewka, M. Krzeminska-pakula, P. Lipiec, J. Peruga, T. Jezewski et al., Effect of Intracoronary Injection of Mononuclear Bone Marrow Stem Cells on Left Ventricular Function in Patients With Acute Myocardial Infarction, The American Journal of Cardiology, vol.104, issue.10, pp.1336-1342, 2009.
DOI : 10.1016/j.amjcard.2009.06.057

V. Schachinger, S. Erbs, A. Elsasser, W. Haberbosch, R. Hambrecht et al., Intracoronary Bone Marrow???Derived Progenitor Cells in Acute Myocardial Infarction, New England Journal of Medicine, vol.355, issue.12, pp.1210-1221, 2006.
DOI : 10.1056/NEJMoa060186

D. Surder, R. Manka, C. Lo, V. Moccetti, T. Rufibach et al., Intracoronary Injection of Bone Marrow Derived Mononuclear Cells, Early or Late after Acute Myocardial Infarction: Effects on Global Left Ventricular Function Four months results of the SWISS-AMI trial, Circulation, 2013.

J. Traverse, D. Mckenna, K. Harvey, B. Jorgenso, R. Olson et al., Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction, American Heart Journal, vol.160, issue.3, pp.428-434, 2010.
DOI : 10.1016/j.ahj.2010.06.009

J. Traverse, T. Henry, S. Ellis, C. Pepine, J. Willerson et al., Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells 2 to 3 Weeks Following Acute Myocardial Infarction on Left Ventricular Function, Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial, pp.2110-2119, 2011.
DOI : 10.1001/jama.2011.1670

J. Traverse, T. Henry, C. Pepine, J. Willerson, D. Zhao et al., Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction, JAMA, vol.308, issue.22, pp.2380-2389, 2012.
DOI : 10.1001/jama.2012.28726

R. Turan, T. Bozdag, C. Turan, J. Ortak, I. Akin et al., Enhanced mobilization of the bone marrow-derived circulating progenitor cells by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction, Journal of Cellular and Molecular Medicine, vol.16, issue.4, pp.852-864, 2012.
DOI : 10.1111/j.1582-4934.2011.01358.x

K. Wollert, G. Meyer, J. Lotz, S. Ringes-lichtenberg, P. Lippolt et al., Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial, The Lancet, vol.364, issue.9429, pp.141-148, 2004.
DOI : 10.1016/S0140-6736(04)16626-9

R. Dersimonian and N. Laird, Meta-analysis in clinical trials, Controlled Clinical Trials, vol.7, issue.3, pp.177-188, 1986.
DOI : 10.1016/0197-2456(86)90046-2

R. Corti, Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study, SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI)

H. Zimmet, P. Porapakkham, P. Porapakkham, Y. Sata, S. Haas et al., Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials, European Journal of Heart Failure, vol.27, issue.9 Suppl, pp.91-105, 2012.
DOI : 10.1093/eurjhf/hfr148

V. Jeevanantham, M. Butler, A. Saad, A. Latif, E. Zuba-surma et al., Adult Bone Marrow Cell Therapy Improves Survival and Induces Long-Term Improvement in Cardiac Parameters: A Systematic Review and Meta-Analysis, Circulation, vol.126, issue.5, pp.551-568, 2012.
DOI : 10.1161/CIRCULATIONAHA.111.086074

A. Balbarini, M. Barsotti, S. Di, A. Leone, and T. Santoni, Circulating Endothelial Progenitor Cells Characterization, Function and Relationship with Cardiovascular Risk Factors, Current Pharmaceutical Design, vol.13, issue.16, pp.1699-1713, 2007.
DOI : 10.2174/138161207780831329

T. Rando, Stem cells, ageing and the quest for immortality, Nature, vol.37, issue.7097, pp.1080-1086, 2006.
DOI : 10.1038/nature04958

A. Ayala-lugo, A. Tavares, A. Paz, A. Alegretti, L. Miquelito et al., Age-Dependent Availability and Functionality of Bone Marrow Stem Cells in an Experimental Model of Acute and Chronic Myocardial Infarction, Cell Transplantation, vol.20, issue.3, pp.407-419, 2010.
DOI : 10.3727/096368909X519283

C. Heeschen, R. Lehmann, J. Honold, B. Assmus, A. Aicher et al., Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart Disease, Circulation, vol.109, issue.13, pp.1615-1622, 2004.
DOI : 10.1161/01.CIR.0000124476.32871.E3

C. Heiss, S. Keymel, U. Niesler, J. Ziemann, M. Kelm et al., Impaired Progenitor Cell Activity in Age-Related Endothelial Dysfunction, Journal of the American College of Cardiology, vol.45, issue.9, pp.1441-1448, 2005.
DOI : 10.1016/j.jacc.2004.12.074

X. Wang, J. Takagawa, V. Lam, D. Haddad, D. Tobler et al., Donor Myocardial Infarction Impairs the Therapeutic Potential of Bone Marrow Cells by an Interleukin-1-Mediated Inflammatory Response, Science Translational Medicine, vol.3, issue.100, pp.100-90, 2011.
DOI : 10.1126/scitranslmed.3002814

G. Fadini, M. Miorin, M. Facco, S. Bonamico, I. Baesso et al., Circulating Endothelial Progenitor Cells Are Reduced in Peripheral Vascular Complications of Type 2 Diabetes Mellitus, Journal of the American College of Cardiology, vol.45, issue.9, pp.1449-1457, 2005.
DOI : 10.1016/j.jacc.2004.11.067

C. Loomans, E. De-koning, F. Staal, M. Rookmaaker, C. Verseyden et al., Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes, Diabetes, vol.53, issue.1, pp.195-199, 2004.
DOI : 10.2337/diabetes.53.1.195

G. Fadini, S. Sartore, M. Albiero, I. Baesso, E. Murphy et al., Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.9, pp.2140-2146, 2006.
DOI : 10.1161/01.ATV.0000237750.44469.88

T. Reffelmann, S. Konemann, and R. Kloner, Promise of Blood- and Bone Marrow-Derived Stem Cell Transplantation for Functional Cardiac Repair, Journal of the American College of Cardiology, vol.53, issue.4, pp.305-308, 2009.
DOI : 10.1016/j.jacc.2008.10.018

D. Clifford, S. Fisher, S. Brunskill, C. Doree, A. Mathur et al., Stem cell treatment for acute myocardial infarction, Cochrane Database Syst Rev, vol.29, issue.15, p.6536, 2012.
DOI : 10.1002/14651858.CD006536.pub3